S&P 500
7,556.60
-0.42%
Dow Jones
52,599.00
-0.30%
Nasdaq 100
29,511.80
-1.25%
Russell 2000
2,965.48
-0.57%
FTSE 100
10,506.00
-0.36%
Nikkei 225
67,929.70
-2.00%

Investing

Today’s Best Market Rumors (9/29/2009) (AMD)(GOOG)(AMGN)

Photo of Douglas A. McIntyre
By Douglas A. McIntyre Updated Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

Updated throughout the day.

Update:  Xerox (XRX) may find that IBM (IBM) or HP (HPQ) outbid it for ACS (ACS)  (Barron’s)

Update:  Apple (AAPL) may be working on a touchscreen remote for an upcoming TV product.  (The Boy Genius Report)

Update: Sequenom (SQNM) is recovering some losses, perhaps due to rumors it may be sold (TheStreet)

Warner Music (WMG) may be near a licensing deal with Google’s (GOOG) YouTube. (WSJ)

Hedge fund manager John Paulson may try to merge CIT (CIT) with IndyMac Federal Bank (NYPost)

Cytokinetics (CYTK) continues to rise despite denying rumorsthat it may be bought by Amgen (AMGN) (DJ Newswires).

AMD (AMD) could be at riskfor bankruptcy. (MarketWatch)

Alexion Pharmaceuticals (ALXN) and Vertex Pharmaceuticals (VRTX) may be acquisition targets.  (The Deal)

Douglas A. McIntyre

Contact [email protected] for any questions or corrections.

Disclaimer: Energy Exploration Technologies, Inc. ("EnergyX") has engaged 24/7 Wall St to publish this communication in connection with EnergyX's ongoing Regulation A offering. 24/7 Wall St has been paid in cash and may receive additional compensation. 24/7 Wall St and/or its affiliates do not currently hold securities of EnergyX.

This compensation and any current or future ownership interest could create a conflict of interest. Please consider this disclosure alongside EnergyX's offering materials. EnergyX's Regulation A offering has been qualified by the SEC. Offers and sales may be made only by means of the qualified offering circular. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at invest.energyx.com/.

Comparisons to other companies are for informational purposes only and should not imply similar results. Past performance is not indicative of future results. Market shortfall are forward‑looking estimates and are subject to substantial uncertainty. Investments in private placements, and start-up investments in particular, are long-term, illiquid, speculative and involve a high degree of risk and those investors who cannot afford to lose their entire investment should not invest in start-ups

Follow 24/7 Wall St. on Google
Photo of Douglas A. McIntyre
About the Author Douglas A. McIntyre →

Douglas A. McIntyre is the co-founder, chief executive officer and editor in chief of 24/7 Wall St. and 24/7 Tempo. He has held these jobs since 2006.

McIntyre has written thousands of articles for 24/7 Wall St. He is an expert on corporate finance, the automotive industry, media companies and international finance. He has edited articles on national demographics, sports, personal income and travel.

His work has been quoted or mentioned in The New York Times, The Wall Street Journal, Los Angeles Times, The Washington Post, NBC News, Time, The New Yorker, HuffPost USA Today, Business Insider, Yahoo, AOL, MarketWatch, The Atlantic, Bloomberg, New York Post, Chicago Tribune, Forbes, The Guardian and many other major publications. McIntyre has been a guest on CNBC, the BBC and television and radio stations across the country.

A magna cum laude graduate of Harvard College, McIntyre also was president of The Harvard Advocate. Founded in 1866, the Advocate is the oldest college publication in the United States.

TheStreet.com, Comps.com and Edgar Online are some of the public companies for which McIntyre served on the board of directors. He was a Vicinity Corporation board member when the company was sold to Microsoft in 2002. He served on the audit committees of some of these companies.

McIntyre has been the CEO of FutureSource, a provider of trading terminals and news to commodities and futures traders. He was president of Switchboard, the online phone directory company. He served as chairman and CEO of On2 Technologies, the video compression company that provided video compression software for Adobe’s Flash. Google bought On2 in 2009.

Continue Reading

Jon C. Ogg |

M&A Watch: Biotech Deals Keep Rolling, Who Is The Next Buyout Target? (TEVA, VRX, CEPH, CRA, ALXN, DNDN, CBST, HGSI, UTHR, CADX, AMAG, SGMO)

Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) has trumped Valeant Pharmaceuticals International, Inc. (NYSE: VRX) after it agreed to acquire Cephalon Inc. (NASDAQ:…

Top 10 Biopharma Events Kicking Off 2018
Chris Lange |

Top 10 Biopharma Events Kicking Off 2018

Jefferies has put together a list of 10 biotech companies that could have developments coming up in the next two…

Why the Teva Acquisition Proves It Is a Stock to Own for the Decade
Chris Lange |

Why the Teva Acquisition Proves It Is a Stock to Own for the Decade

Even though the trend toward generic drugs is only likely to grow, the drug price pressures hanging over the sector…

Jon C. Ogg |

Key Changes Made on the UBS Key Call List (UBS, WCRX, STZ, BUD)

We wrote at great length last month about the Key Call and Conviction Buy lists from the major Wall St.…

Valeant CEO Michael Pearson Should Resign
Douglas A. McIntyre |

Valeant CEO Michael Pearson Should Resign

Valeant Pharmaceuticals International CEO Michael Pearson needs to leave the company he leads, as its problems continue to grow rapidly.

Jon C. Ogg |

BioHealth Business Daily (ACAD, AEN, DNDN, EXAS, ITMN, MIPI, OREX, OSIP, RNN, SLXP, VVUS)

We are seeing many news-related movers in today’s edition of the BioHealth Business Daily.  ACADIA Pharmaceuticals, Inc. (NASDAQ: ACAD), Adeona…

Major Biopharma Catalysts and FDA Events to Look For in March
Chris Lange |

Major Biopharma Catalysts and FDA Events to Look For in March

24/7 Wall St. includes a calendar of a few of the biggest companies expecting clinical trial and FDA updates in…

Douglas A. McIntyre |

Top Day Trader Alerts (AAPL, BPAX, CAT, FNM, FRE, MGM, NVAX)

These are this morning’s top day trader alerts.  We have more detailed price and volume data along with added color…

SGEN, ACAD & BMEA Drove Baker Brothers Advisors’ Q1 Returns as ASND and HZNP Were Culled
247patrick |

SGEN, ACAD & BMEA Drove Baker Brothers Advisors’ Q1 Returns as ASND and HZNP Were Culled

Baker Brothers Advisors first-quarter investment update revealed several new positions, as well as further investment into high-conviction investments.

Top Gaining Stocks

Intuit
INTU • Vol: 1,271,102
Salesforce
CRM • Vol: 3,425,740
Trade Desk
TTD • Vol: 4,377,135
FactSet Research Systems
FDS • Vol: 150,035
Cognizant
CTSH • Vol: 1,961,326

Top Losing Stocks

Coterra Energy
CTRA • Vol: 73,319,495
Western Digital
WDC • Vol: 1,715,814
Lam Research
LRCX • Vol: 2,211,952
ON Semiconductor
ON • Vol: 2,074,452
Seagate Technology
STX • Vol: 1,087,267